Abstract

Allergic rhinitis (AR) is a nose symptomatic affection induced by exposure to allergens, immunoglobulin E (IgE) mediated and characterized by inflammation of the nasal mucosa. The cardinal symptoms are the nasal obstruction, sneezing, and watery rhinorrhea. Furthermore, conjunctival hyperemia and nasal, oropharyngeal, and ocular pruritus are also part of these symptoms, which may be resolved spontaneously or by treatment [1,2]. Allergic rhinitis is a public health problem, and its prevalence has considerably increased in recent decades. It is the most prevalent chronic disease caused by allergy in childhood. Although it does not cause direct risk of life, it can cause a significant effect on patient’s quality of life, as well as exacerbate a large number of comorbidities, such as, asthma and sinusitis [1].